P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE. (23rd June 2022) - Vaxman, I.; Kumar, S.; buadi, F.; Lacy, M.; Dingli, D.; Fonder, A.; Hobbs, M.; Hayman, S.; hwa, L. Y.; Kouralis, T.; Warsame, R.; Muchtar, E.; et al.